Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | G6PD | P11413 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | KMO | O15229 | 3/20 | 0.43 |
| ▸ | KYNU | Q16719 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | ALPI | P09923 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.40 |
| ▸ | CASR | P41180 | 1/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.38 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.38 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.38 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.38 |
| ▸ | GRM3 | Q14832 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29934345 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL16616577 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL17641540 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL30973707 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL134058 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL29375641 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL29352838 | 1.00 | KDM4E (1.00) | KDM4EHIF1ATDP1G6PDCASP7 | |
| Water SCHEMBL8081334 | 0.98 | KDM4E (0.97) | KDM4EHIF1ATDP1G6PDCASP7 | |
| Kynurenine SCHEMBL6932225 | 0.87 | KDM4E (0.77) | KDM4EHIF1ATDP1G6PDCASP7 | |
| SCHEMBL19260994 | 0.86 | KDM4E (0.75) | KDM4EHIF1ATDP1G6PDCASP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2275 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098007-A1 | Compounds and Their Use in Filtering Ultraviolet and/or High-Energy Visible Light | SOLIOME INC (US) | 2026-04-09 | — | — | US | claimed |
| US-12551459-B2 | Combination of kynurenine and antigen presenting cells (APC) as therapeutics and methods for their use in immune modulation | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2026-02-17 | — | — | US | claimed |
| EP-4648788-A1 | LIPID BINDING PROTEIN MOLECULE THERAPY | Abionyx Pharma SA (FR) | 2025-11-19 | — | — | EP | claimed |
| US-20250255792-A1 | Methods of Using a Small Molecule Chemical Compound to Reduce the Appearance of Rhytids and Wrinkles | BIRCHBIOMED INC. (CA) | 2025-08-14 | — | — | US | claimed |
| EP-4587007-A2 | COMPOUNDS AND THEIR USE IN FILTERING ULTRAVIOLET AND/OR HIGH-ENERGY VISIBLE LIGHT | Soliome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| EP-4572737-A1 | METHODS OF USING A SMALL MOLECULE CHEMICAL COMPOUND TO REDUCE THE APPEARANCE OF RHYTIDS AND WRINKLES | Birchbiomed Inc. (CA) | 2025-06-25 | — | — | EP | claimed |
| EP-4551232-A1 | METABOLOMIC IMPROVEMENTS USING RESISTANT STARCH SUPPLEMENTATION | Mcpharma Biotech Inc. (CA) | 2025-05-14 | — | — | EP | claimed |
| CN-119894495-A | Method for reducing wrinkle and crease appearance using small molecule compounds | 伯奇生物医药有限公司 | 2025-04-25 | — | — | CN | claimed |
| EP-4535004-A1 | METHOD FOR ASSISTING DIAGNOSIS OF BLOOD TUMOR, METHOD FOR OBTAINING DATA FOR DIAGNOSING BLOOD TUMOR, AND KIT FOR SAID METHODS | FUJIFILM Corporation (JP) | 2025-04-09 | — | — | EP | claimed |
| WO-2025068213-A1 | USE OF A MARKER SET FOR DETERMINING THE RISK OF HAVING OR DEVELOPING BLADDER CANCER | NUMARES AG (DE) | 2025-04-03 | — | — | WO | claimed |
| EP-1093580-A1 | DIAGNOSIS OF PREDISPOSITION TO EPILEPSY AND MONITORING OF ANTIEPILEPTIC TREATMENT | Advanced Neuroprotective Systems Ltd. (IL) | 2001-04-25 | — | — | EP | claimed |
| WO-2001001963-A1 | A METHOD FOR THE IMPROVEMENT OF TRANSPORT ACROSS ADAPTABLE SEMI-PERMEABLE BARRIERS | IDEA AG (DE) | 2001-01-11 | — | — | WO | claimed |
| WO-2001001962-A1 | A METHOD FOR THE IMPROVEMENT OF TRANSPORT ACROSS ADAPTABLE SEMI-PERMEABLE BARRIERS | IDEA AG. (DE) | 2001-01-11 | — | — | WO | claimed |
| CN-1275060-A | Liver function test | NORGINE LTD (GB) | 2000-11-29 | — | — | CN | claimed |
| EP-1003458-A2 | LIVER FUNCTION TEST | Norgine Limited (GB) | 2000-05-31 | — | — | EP | claimed |
| US-6030841-A | PROCESSING SERIES OF BLOOD SAMPLES OBTAINED AT TIMED INTERVALS AFTER INTRAVENOUS INJECTION OF COLORED/FLUORESCENT BILE ACID DERIVATIVE TO OBTAIN PLASMA, MEASURING COLOR OR FLUORESCENCE, FITTING TO PLASMA ELIMINATION CURVE, COMPARING | NORGINE LIMITED (GB) | 2000-02-29 | — | — | US | claimed |
| WO-1999058968-A1 | DIAGNOSIS OF PREDISPOSITION TO EPILEPSY AND MONITORING OF ANTIEPILEPTIC TREATMENT | ADVANCED NEUROPROTECTIVE SYSTEMS LTD. (IL) | 1999-11-18 | — | — | WO | claimed |
| WO-1999007325-A1 | LIVER FUNCTION TEST | NORGINE LIMITED (GB) | 1999-02-18 | — | — | WO | claimed |
| EP-0844890-A1 | THE USE OF BILE ACID DERIVATIVES | THE UNIVERSITY OF BIRMINGHAM (GB) | 1998-06-03 | — | — | EP | claimed |
| WO-1997006829-A1 | THE USE OF BILE ACID DERIVATIVES | THE UNIVERSITY OF BIRMINGHAM (GB) | 1997-02-27 | — | — | WO | claimed |